术前甲状腺参数,侵袭性临床病理特征和差异化甲状腺癌复发风险之间的关联
Lu Yu1, Xiao Chen1, Jiaqi Liu1
1Department of Endocrinology and Metabolism, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Annals of medicine
|April 12, 2025
概括
侵略性的临床病理特征和手术前甲状腺激素水平,包括自由三甲状腺素 (FT3) 和自由甲状腺素 (FT4),预测更高的分化甲状腺癌 (DTC) 复发风险. 这些因素增强了美国甲状腺协会 (ATA) 的风险分层系统,以更好地管理患者.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 差异化甲状腺癌 (DTC) 管理依赖于准确的复发风险分层.
- 美国甲状腺协会 (ATA) 提供了一个风险分类系统,但它的改进正在进行中.
- 了解额外的预测因素可以优化患者管理策略.
研究的目的:
- 调查DTC中侵略性临床病理学特征与ATA复发风险之间的关联.
- 评估手术前甲状腺参数在预测DTC复发风险中的预后价值.
- 通过新型预测器增强现有的ATA风险分层系统.
主要方法:
- 对3833名经组织学确认的DTC患者的术前和术后数据的回顾性分析.
- 将患者分为低和中高至高的ATA复发风险组.
- 多变量分析以确定较高ATA复发风险的独立预测因素.
主要成果:
- 男性性别,年龄较大 (≥52岁),瘤大小,神经入侵,边缘参与,多焦点和双边性与更高的ATA复发风险有关.
- 在手术前增加的自由三甲状腺素 (FT3),更高的FT3与自由甲状腺素 (FT3/FT4) 比率,以及较低的甲状腺反量基指数 (TFQI) 水平与复发风险增加相关.
- 结合这些因素的预测模型显示出出色的歧视 (AUC = 0.836).
结论:
- 临床病理因素 (男性性别,年龄,瘤特征) 和手术前甲状腺参数 (FT3,FT3/FT4,TFQI) 是DTC复发风险的有价值的互补预测因素.
- 这些发现支持对差异化甲状腺癌目前的风险分层方法的改进.
- 这些预测因素的整合可以导致更细致和优化的患者管理.
更多相关视频
相关概念视频
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...


